There is a 340B angle in the fight in the U.S. House over who should be third in the Republican leadership ranks.
The GOP caucus is expected to vote tomorrow to remove Rep. Liz Cheney (R-Wyo.) as House Republican Conference
…
Articles by : Ron Shinkman,
Commercially insured patients with deductibles and coinsurance pay more when manufacturers raise a drug’s list price and do not directly benefit from the confidential rebates paid by manufacturers to insurers, according to a study published this morning in JAMA Open
…
Between 3% and 5% of 340B drug discounts and Medicaid drug rebates are duplicates, adding up to at least $933 million and potentially as high as $1.6 billion in additional costs to the pharmaceutical industry in 2019, according to new
…
UPDATED Monday, April 26, 2021, 9:00 a.m. EDT—President Biden signed the two bills into law on April 23.
The U.S. House of Representatives passed two bills last week intended to reduce the overall costs of medications by boosting competition for
…
Drug manufacturer Gilead late last week announced a huge cut, effective Jan. 1, 2022, in pharmacy reimbursement for its HIV and hepatitis B medicines that uninsured individuals get for free through Gilead’s Advancing Access patient assistance program (PAP). 340B HIV/AIDS
…
New York state lawmakers and Gov. Andrew Cuomo (D) agreed this week to postpone transferring Medicaid managed care prescription drug benefits to Medicaid fee for service (FFS) for two years, temporarily averting a significant financial loss to 340B covered entities.
…
(Updated Tuesday, April 6, 2021, 4:00 p.m. EDT—Individuals who were among CV340B’s Notable Women of 340B were excluded from the original version of this article. They have been added to the list at the end.)
Women have played a key
…